Product
ATG-037
Name
ATG-037
1 clinical trial
1 drug
1 indication
Indication
Metastatic Solid TumorsDrug
ATG-037Clinical trial
A Phase I/Ib, Multi-center, Open-label, and Dose-finding Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG-037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Locally Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2027-08-30